Question explored with the scientific record
Slow gastric emptying and slow transit constipation - recommendations for investigations
The short version: the evidence for diagnostic investigations in slow gastric emptying and slow-transit constipation is thin, conflicted, and mostly funded by the system that profits from the procedures.
The evidence you have is a mixed bag. One 2020 review [3] lists the standard toolkit: radiopaque markers, scintigraphy, wireless motility capsule, high-resolution anorectal manometry, defecography, and MRI defecography. But it does not give you the numbers that matter: how often each test changes the diagnosis or the treatment plan. A 2025 narrative review [5] repeats the Rome IV criteria and the radiopaque marker method, but it is a review, not a trial. No study in your evidence compares the diagnostic yield of these tests head-to-head in the same patients.
The 2025 study on the Cajal subtype [4] is the most specific: it looked at 21 patients who had already had a colectomy. Their mean interval between bowel movements was 12.2 days, and 95% needed manual assistance. That tells you the severity of the disease in the surgical population, but it does not tell you how to find those patients earlier. The study was retrospective, and the reference group was 70 people without the condition, not a blinded diagnostic comparison.
The 2010 colectomy study [2] is older and shows that operated patients had a mean colon transit time of 65 hours versus 24.75 hours in controls. That is a big difference, but the study was partly retrospective and the surgical group was small (35 patients). The complication rate was real: 2 anastomotic leaks, 1 death, 2 wound infections.
The 2020 SPECT/CT study [1] on reflux is only 17 adults and was not designed for constipation. The 1997 and 1995 electrogastrography studies [7, 8] are decades old and on different populations (esophageal atresia, achalasia). The 2014 fludrocortisone study [9] in 16 children with orthostatic intolerance found universal gastric dysrhythmias, but that is a very specific subgroup.
What is missing. No study in your evidence compares the diagnostic accuracy of scintigraphy versus wireless motility capsule versus radiopaque markers in the same patients with suspected slow transit. No study gives you the positive and negative likelihood ratios for any test. No study tells you how often the test result changes the management. The 2020 review [3] mentions the London Classification and international consensus, but consensus is not evidence.
The money pipeline. The 2010 review [18] on management strategies lists a conflict of interest: the author provided scientific advice to Coloplast, GlaxoSmithKline, Medtronic, Movetis, Mundipharma, Pfizer, and Takeda. That is seven companies that make drugs or devices for constipation. The 2018 review [19] on medical therapy is a narrative review, not a trial. The dietary management review [16] is from 2025 and summarizes RCTs on psyllium, kiwifruit, prunes, and magnesium oxide, but those are treatments, not diagnostics.
| Test | What it measures | Evidence quality in your retrieval |
|---|---|---|
| Radiopaque marker study | Colon transit time | Mentioned in 2020 review [3] and 2025 review [5], no diagnostic accuracy data |
| Scintigraphy | Gastric emptying and colon transit | 2020 SPECT/CT study [1] on reflux, not constipation |
| Wireless motility capsule | Whole gut transit | Listed in 2020 review [3], no accuracy data |
| High-resolution anorectal manometry | Evacuation disorder | Listed in 2020 review [3], no accuracy data |
| Defecography | Structural and functional evacuation | Listed in 2020 review [3], no accuracy data |
| Electrogastrography | Gastric myoelectrical activity | 1997 [7], 1995 [8], 2014 [9] studies, all small and on different populations |
My call: the standard investigations exist but the evidence for their diagnostic accuracy in slow gastric emptying and slow-transit constipation is not clear from the studies you have. The tests are worth doing if the result will change management, but the data to support that is absent. Confidence: low.
Sources used 11
-
A transformational change in scintigraphic gastroesophageal reflux studies: A comparison with historic techniques
Hybrid SPECT/CT scintigraphy with ROI-based quantitation detects gastroesophageal reflux with 82.4% accuracy in 17 adults and reveals extraesophageal reflux (laryngopharyngeal and pulmonary) not evident with historic techniques, suggesting improved diagnostic value.
DOI: 10.1111/cpf.12677 -
Colectomy for refractory constipation
A Danish prospective/retrospective study evaluating colectomy options for refractory constipation, detailing the type of colectomy, postoperative complications, functional outcomes, patient satisfaction, and differences in colon transit time, fecal load, and colon length between…
DOI: 10.3109/00365521003587796 -
Chronic constipation in adults: Contemporary perspectives and clinical challenges. 1: Epidemiology, diagnosis, clinical associations, pathophysiology and investigation
This article provides a contemporary, comprehensive overview of chronic constipation in adults, focusing on epidemiology, diagnosis, clinical associations, pathophysiology, and investigative approaches, and highlighting hot topics and areas for future research.
DOI: 10.1111/nmo.14050 -
Clinical-anamnestic characteristics and quality of life in patients with the Cajal subtype of chronic slow-transit constipation
Patients with the Cajal subtype of chronic slow-transit constipation who underwent colectomy had early disease onset, long duration, frequent family history, severe bowel dysfunction, and significantly worse PAC-QOL scores than a reference group.
DOI: 10.30978/gs-2025-2-44 -
Slow transit syndrome and mechanisms of constipation (lazy bowel syndrome): current understanding of causes, diagnosis, and consequences
This narrative review summarizes slow transit syndrome and functional constipation (lazy bowel syndrome) as a multifactorial motility disorder, outlining Rome IV criteria, radiopaque marker diagnosis, and stepwise therapy from diet and lifestyle to osmotic laxatives and prucalop…
DOI: 10.51793/os.2025.28.12.007 -
Electrogastrography after operative repair of esophageal atresia
This study investigates postoperative gastric electrical control activity in children with esophageal atresia using electrogastrography, revealing significant dysrhythmias and suggesting potential gastric motility disorders despite asymptomatic presentations.
DOI: 10.1007/BF01076934 -
Helicobacter pylori infection and chronic gastritis are less common in reflux esophagitis
This study investigates gastric dysrhythmias in patients with achalasia compared to healthy controls, revealing significant differences in gastric electrical activity and its correlation with the duration and grading of achalasia.
DOI: 10.1016/0016-5085(95)23007-6 -
Effect of Fludrocortisone Acetate on Chronic Unexplained Nausea and Abdominal Pain in Children With Orthostatic Intolerance
A small prospective study in 16 female children with orthostatic intolerance shows that fludrocortisone acetate improves several GI and autonomic symptoms (nausea, dizziness, abdominal pain, flushing, missing school) and reveals universal pre-treatment gastric dysrhythmias on el…
DOI: 10.1097/mpg.0000000000000305 -
Dietary management of chronic constipation: a review of evidence-based strategies and clinical guidelines
This review synthesizes current evidence on the dietary management of chronic constipation and evaluates international clinical guidelines, highlighting effective dietary strategies (e.g., psyllium, kiwifruit, prunes, magnesium oxide, certain probiotics) and identifying gaps/lim…
DOI: 10.1017/s0029665125100694 -
Current management strategies and therapeutic targets in chronic constipation
This article is a comprehensive narrative review of current and emerging management strategies for chronic constipation, evaluating evidence across lifestyle measures, biofeedback, laxatives, prokinetics, serotonergic agents, opioid antagonists, chloride channel activators, neur…
DOI: 10.1177/1756283x10384173 -
Medical Therapy of Constipation: Current Standards and Beyond
A comprehensive review of current standards and future directions in medical therapy of chronic constipation, outlining a stepwise management approach and the roles of prokinetics, secretagogues, and PAMORA agents for opioid-induced constipation.
DOI: 10.1159/000488695